New research from Karolinska Institutet shows how estrogen protects against MASLD, a fatty liver disease that has increased dramatically during the current obesity epidemic. The study, published in Molecular Systems Biology, ...
Mar 8, 2024
0
0
Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.
Feb 16, 2021
0
3
It's not the amount of fat in your body but where it's stored that may increase your risk for heart attack, stroke and diabetes, according to a new study presented today at the annual meeting of the Radiological Society of ...
Nov 28, 2017
0
0
Researchers have developed a diagnostic model that is highly predictive of nonalcoholic fatty liver disease (NAFLD). Referred to as the Framingham Steatosis Index (FSI), this novel model may become a cheaper and easier alternative ...
Jul 13, 2016
0
0
Exposure during infancy to the common plasticizer bisphenol A (BPA) "hijacks" and reprograms genes in the liver of newborn rats, leading to nonalcoholic fatty liver disease (NAFLD) in adulthood. A new study has found how ...
Apr 2, 2017
0
4
A new study shows a brisk walk is just as good as a jog when it comes to reducing liver fatty content, important news for the more than 3 million people diagnosed each year in the U.S. with nonalcoholic fatty liver disease ...
Jul 6, 2016
0
0
New born human infants have the largest brains among primates, but also the highest proportion of body fat. Before birth, if the supply of nutrients from the mother through the placenta is limited or unbalanced, the developing ...
Aug 22, 2012
0
0
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic ...
Apr 23, 2015
0
5
New data presented today at The International Liver Congress 2016 in Barcelona, Spain, demonstrates that the drug sitagliptin - more commonly used to treat diabetes - was no more effective than placebo for reducing non-alcoholic ...
Apr 16, 2016
0
4
As obesity rates rise in the United States, so does the incidence of liver diseases. In fact, 80 percent of obese people are believed to have non-alcoholic fatty liver disease, or NAFLD, while another related liver disorder, ...
Nov 18, 2016
0
2
